Literature DB >> 17065206

Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.

Melanie D Bird1, Chin-Fun Chu, Alison J Johnson, Gregg N Milligan.   

Abstract

Early clearance of a thymidine kinase-deficient strain of herpes simplex virus type 2 from the female genital tract required T-cell-produced gamma interferon (IFN-gamma). Transfer of activated CD8+ T cells to irradiated C57BL/6 mice resulted in rapid virus clearance, but clearance was greatly delayed in recipients deficient in the IFN-gamma receptor (IFN-gammaR). Early virus clearance was demonstrated in radiation chimeras in which IFN-gammaR expression was limited to parenchymal cells, but resolution was significantly delayed in chimeras deficient in IFN-gammaR expression and chimeras expressing IFN-gammaR only on hematopoietic cells. Together, these results suggest that early IFN-gamma-mediated protection was manifested mainly by stimulation of genital parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065206      PMCID: PMC1797257          DOI: 10.1128/JVI.01455-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Authors:  D M Koelle; C M Posavad; G R Barnum; M L Johnson; J M Frank; L Corey
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 2.  The IFN gamma receptor: a paradigm for cytokine receptor signaling.

Authors:  E A Bach; M Aguet; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Molecular cloning and expression of the human interferon-gamma receptor.

Authors:  M Aguet; Z Dembić; G Merlin
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

4.  Role of interferon-gamma in immunity to herpes simplex virus.

Authors:  Z Yu; E Manickan; B T Rouse
Journal:  J Leukoc Biol       Date:  1996-10       Impact factor: 4.962

5.  Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.

Authors:  G N Milligan; D I Bernstein
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

6.  In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1.

Authors:  R Rossol-Voth; S Rossol; K H Schütt; S Corridori; W de Cian; D Falke
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

7.  Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.

Authors:  D M Koelle; H Abbo; A Peck; K Ziegweid; L Corey
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

8.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

Authors:  P M Smith; R M Wolcott; R Chervenak; S R Jennings
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.

Authors:  G N Milligan; D I Bernstein; N Bourne
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

View more
  8 in total

1.  Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions.

Authors:  Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Alison J Johnson; Brian M Friedrich; Windy R Allman; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2011-03-27       Impact factor: 4.054

2.  Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4+ T Lymphocytes.

Authors:  Nigel Bourne; Clarice L Perry; Brianne N Banasik; Aaron L Miller; Mellodee White; Richard B Pyles; Hubert Schäfer; Gregg N Milligan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.

Authors:  Xiuli Zhang; Xavier Dervillez; Aziz Alami Chentoufi; Tina Badakhshan; Ilham Bettahi; Lbachir Benmohamed
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

4.  Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Authors:  Christopher D Conrady; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

5.  Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.

Authors:  Alison J Johnson; Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2009-11-25       Impact factor: 4.054

6.  Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.

Authors:  Richard B Pyles; Kathleen L Vincent; Marc M Baum; Barry Elsom; Aaron L Miller; Carrie Maxwell; Tonyia D Eaves-Pyles; Guangyu Li; Vsevolod L Popov; Rebecca J Nusbaum; Monique R Ferguson
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 7.  Herpes Simplex Virus Evasion of Early Host Antiviral Responses.

Authors:  Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

8.  Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus.

Authors:  Norifumi Iijima; Melissa M Linehan; Melodie Zamora; Debbie Butkus; Robert Dunn; Marilyn R Kehry; Terri M Laufer; Akiko Iwasaki
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.